abstract |
Disclosed is the use of a dietary fiber aggregation in which water-soluble beta-glucan is the dietary fiber present in the highest amount, in the manufacture of a medicament for treating or preventing metabolic syndrome, wherein the dietary fiber aggregation is obtained from one or more sources selected from the group consisting of barley, oats, rye and adlay. |